Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...

Enlicitide, which could be the first oral medication that blocks the protein PCSK9, helped cut cholesterol levels in a pair ...

It’s a truth that all clinical teams are aware of: risk mitigation is a core part of clinical trial success. But, what does ...